Pulmonary hypertension module 4: special groups

Released 2 December 2016     Expires: 02 December 2018      Programme: Pulmonary hypertension 0.5 CPD/CME credits

Sponsorship Statement: The original programme was sponsored by an educational grant from Pfizer. Pfizer had no role in the writing of the modules and had no editorial control over the content. The original programme was revised by BJC Learning in 2016.

Designed to give healthcare professionals a review of special groups relevant to PAH, this is one of several modules in our PAH programme.

Module first published: 14 June 2013
Revised module released: 02 December 2016

0.5 CPD/CME credits

Learning objectives

After completing this module, participants should be better able to:
• Understand the association between PAH and congenital heart disease
• Understand the association between PAH and connective tissue diseases
• Review patient support groups for pulmonary hypertension in the UK

Faculty

Editor
Dr Simon Gibbs, Clinical Senior Lecturer in Cardiology, National Heart and Lung Institute, Imperial College London, and Lead Clinician, National Pulmonary Hypertension Service, Hammersmith Hospital, London

Contributors
Dr Shareen Jaijee, Honorary Consultant Cardiologist, Imperial College Healthcare Trust, Clinical Research Fellow, Imperial College
Dr Rachel Davies, Consultant Chest Physician, Hammersmith Hospital, London
Dr Luke Howard, Consultant Chest Physician, Hammersmith Hospital, London
Mr David Jenkins, Consultant Cardiothoracic Surgeon, Papworth Hospital, Cambridge
Dr Henry Oluwasefunmi Savage, Specialist Registrar in Cardiology, Imperial College Healthcare Trust, Clinical Research Fellow, Imperial College

Accreditation

0.5 CPD/CME credits, 0.5 hours

BJC Learning has assigned half an hour of CPD/CME credit to this module

Endorsed by:

You need to login to take this module

You need to be a registered member to view this page. It's quick, free and offers you a host of other benefits, including the facility to print and download articles and supplements, access our archived issues and receive email updates when new issues and other content are online.

23 thoughts on “Pulmonary hypertension module 4: special groups”

All rights reserved. No part of this programme may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publishers, Medinews (Cardiology) Limited.

It shall not, by way of trade or otherwise, be lent, re-sold, hired or otherwise circulated without the publisher’s prior consent.

Medical knowledge is constantly changing. As new information becomes available, changes in treatment, procedures, equipment and the use of drugs becomes necessary. The editors/authors/contributors and the publishers have taken care to ensure that the information given in this text is accurate and up to date. Readers are strongly advised to confirm that the information, especially with regard to drug usage, complies with the latest legislation and standards of practice.

Healthcare professionals should consult up-to-date Prescribing Information and the full Summary of Product Characteristics available from the manufacturers before prescribing any product. Medinews (Cardiology) Limited cannot accept responsibility for any errors in prescribing which may occur.